Omotesando Helene Clinic and Maison Privé Clinic Form Medical Partnership

TOKYO, Sept. 25, 2026 /CourierPR/ -- Omotesando Helene Clinic and Maison Privé Clinic have entered into a strategic partnership aimed at enhancing international medical exchange and patient support. The agreement, formalized through a Memorandum of Understanding (MOU), will see the two clinics collaborate in various areas to improve patient experiences and advance medical knowledge.

Under the terms of the agreement, both clinics will share information in medical fields such as regenerative medicine, facilitating a deeper understanding of each other's practices. Staff exchanges are also planned, with the clinics organizing seminars, briefings, and facility tours to promote knowledge sharing and mutual understanding. These exchanges will enable the staff to gain insights into each other's clinical practices and patient care approaches, fostering a more integrated medical community.

Patient support will be a key focus of the collaboration. The clinics will coordinate pre-visit consultations, information sharing, and scheduling to ensure a smooth and stress-free experience for international patients. Interpretation services, guidance on accommodation and local transportation, and support for accompanying persons will also be provided. Additionally, the clinics will offer enhanced concierge services for Very Important and Very Valued Individuals (VIPs and VVIPs), ensuring a seamless journey from pre-visit arrangements to post-visit follow-up.

The partnership will leverage the strengths of both clinics. Maison Privé Clinic, known for its expertise in anti-aging and aesthetic medicine, will combine forces with Omotesando Helene Clinic, which has accumulated knowledge in stem cells, exosomes, and regenerative medicine. This collaboration is part of Omotesando Helene Clinic's broader initiative to expand its clinical knowledge through exchanges with medical institutions both in Japan and abroad.

Omotesando Helene Clinic, a key player in the HELENE BIO Group, is committed to advancing regenerative medicine through the integration of clinical practice, data, cell processing, and research and development. The clinic's role in the HELENE BIO Group underscores its dedication to accumulating and validating insights gained from daily clinical experience and disseminating information that contributes to the advancement of regenerative medicine.

This partnership is expected to enhance the quality of care for patients seeking medical treatment in both Japan and South Korea, while also fostering a collaborative environment that benefits both clinics and their patients.